Literature DB >> 10746013

Beyond mere diversity: tailoring combinatorial libraries for drug discovery.

E J Martin1, R E Critchlow.   

Abstract

Combinatorial library design attempts to choose the best set of substituents for a combinatorial synthetic scheme to maximize the chances of finding a useful compound, such as a drug lead. Initial efforts were focused primarily on maximizing diversity, perhaps allowing some bias by the inclusion of a small, fixed set of pharmacophoric substituents. However, many factors besides diversity impact good library design for drug discovery. A library can be better "tailored" by assigning the candidate substituents to categories such as polar, pharmacophoric, rigid, low molecular weight, and expensive. Stratified sampling by successive steps of D-optimal design generates diverse designs which are also consistent with desirable profiles of these properties. Comparing the diversity scores among design profiles reveals the tradeoffs between diversity, physical property distributions, synthetic difficulty, expense, and pharmacophoric bias. The diversity scores can be calibrated by scoring the best designs from subsets of the candidates made either from specific classes of substituents or by randomly eliminating candidates. This procedure shows how poor random designs are compared even to highly biased optimal designs. Library design requires a synergistic effort between computational and synthetic medicinal chemists, so specialized interactive software has been developed to integrate substructure searching, display, and statistical experimental design to facilitate this interaction for the effective design of well-tailored libraries.

Mesh:

Substances:

Year:  1999        PMID: 10746013     DOI: 10.1021/cc9800024

Source DB:  PubMed          Journal:  J Comb Chem        ISSN: 1520-4766


  22 in total

1.  Comments on the design of chemical libraries for screening.

Authors:  H O Villar; R T Koehler
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

2.  Multiobjective optimization of combinatorial libraries.

Authors:  D K Agrafiotis
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

3.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

4.  Reactant- and product-based approaches to the design of combinatorial libraries.

Authors:  Valerie J Gillet
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

5.  Halogenated benzimidazole carboxamides target integrin alpha4beta1 on T-cell and B-cell lymphomas.

Authors:  Richard D Carpenter; Arutselvan Natarajan; Edmond Y Lau; Mirela Andrei; Danielle M Solano; Felice C Lightstone; Sally J Denardo; Kit S Lam; Mark J Kurth
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

6.  A reagent-based strategy for the design of large combinatorial libraries: a preliminary experimental validation.

Authors:  Gergely M Makara; Huw Nash; Zhongli Zheng; Jean-Paul A Orminati; Edward A Wintner
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

7.  Analysis of selection methodologies for combinatorial library design.

Authors:  Rosalia Pascual; José I Borrell; Jordi Teixidó
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

8.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

9.  Multiobjective optimization of combinatorial libraries.

Authors:  D K Agrafiotis
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

Review 10.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.